{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:34:21Z","timestamp":1791506061934,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jtho.2018.04.034","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T12:59:09Z","timestamp":1525870749000},"page":"1012-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)"],"prefix":"10.1016","volume":"13","author":[{"suffix":"III","given":"Samuel G.","family":"Armato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2018.04.034_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2018.04.034_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2018.04.034_bib4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","article-title":"Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial","volume":"14","author":"Calabr\u00f2","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(15)00092-2","article-title":"Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study","volume":"3","author":"Calabr\u00f2","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtho.2018.04.034_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1999.17.1.25","article-title":"Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study","volume":"17","author":"Byrne","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bjc.6600505","article-title":"A\u00a0multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma","volume":"87","author":"Nowak","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib10","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1200\/JCO.2010.33.7071","article-title":"Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes","volume":"29","author":"Oxnard","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/JTO.0000000000000211","article-title":"Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions","volume":"9","author":"Armato","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1118\/1.1688211","article-title":"Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques","volume":"31","author":"Armato","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.jtho.2018.04.034_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.acra.2005.05.021","article-title":"Evaluation of semi-automated measurements of mesothelioma tumor thickness on CT scans","volume":"12","author":"Armato","year":"2005","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jtho.2018.04.034_bib15","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1118\/1.1812611","article-title":"Automated matching of temporally sequential CT sections","volume":"31","author":"Sensakovic","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.jtho.2018.04.034_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2214\/AJR.05.0076","article-title":"Variability in mesothelioma tumor response classification","volume":"186","author":"Armato","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtho.2018.04.034_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejca.2008.10.028","article-title":"Evaluation of lymph nodes with RECIST 1.1","volume":"45","author":"Schwartz","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/JTO.0b013e31828354c8","article-title":"Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma","volume":"8","author":"Labby","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib20","doi-asserted-by":"crossref","first-page":"1601428","DOI":"10.1183\/13993003.01428-2016","article-title":"Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma","volume":"49","author":"de Perrot","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2018.04.034_bib21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","article-title":"The IASLC Mesothelioma Staging Project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Nowak","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/JTO.0b013e318269fe21","article-title":"Optimization of response classification criteria for patients with malignant mesothelioma","volume":"7","author":"Labby","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1118\/1.3537610","article-title":"Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans","volume":"38","author":"Corson","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.jtho.2018.04.034_bib25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jtho.2016.04.027","article-title":"North American multicenter volumetric CT study for clinical staging of malignant pleural mesothelioma: feasibility and logistics of setting up a quantitative imaging study","volume":"11","author":"Gill","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1148\/radiol.2015142202","article-title":"Metrology standards for quantitative imaging biomarkers","volume":"277","author":"Sullivan","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jtho.2018.04.034_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.lungcan.2014.11.019","article-title":"Radiologic-pathologic correlation of mesothelioma tumor volume","volume":"87","author":"Armato","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/annonc\/mds535","article-title":"Disease volumes as a marker for patient response in malignant pleural mesothelioma","volume":"24","author":"Labby","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5223(98)70274-0","article-title":"Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma","volume":"115","author":"Pass","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2018.04.034_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtho.2018.04.034_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.lungcan.2015.07.011","article-title":"Imaging in pleural mesothelioma: a review of the 12th International Conference of the International Mesothelioma Interest Group","volume":"90","author":"Armato","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejca.2008.10.025","article-title":"RECIST working group. Cancer clinical trial outcomes: any progress in tumour-size assessment?","volume":"45","author":"Verweij","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib35","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib36","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","article-title":"Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2018.04.034_bib37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early\u00a0prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of\u00a0serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jtho.2018.04.034_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","article-title":"Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma","volume":"67","author":"Veit-Haibach","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib39","first-page":"241","article-title":"FDG PET\/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy","volume":"3","author":"Genestreti","year":"2012","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.jtho.2018.04.034_bib40","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1378\/chest.125.6.2356","article-title":"Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis","volume":"125","author":"Kwek","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2018.04.034_bib41","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","article-title":"A\u00a0novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters","volume":"16","author":"Nowak","year":"2010","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1016\/j.jtho.2019.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000}}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086418305963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086418305963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T21:47:01Z","timestamp":1562017621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086418305963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1556086418305963"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2018.04.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733222861.793551920","asserted-by":"object"}]},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2018.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}